tetano
Editor, Senior Moderator
Clin Appl Thromb Hemost
. 2023 Jan-Dec;29:10760296221148477.
doi: 10.1177/10760296221148477.
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis
Forough Mehrabi[SUP] 1 [/SUP], Melina Farshbafnadi[SUP] 2 [/SUP], Nima Rezaei[SUP] 3 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) affects the respiratory system of patients and is characterized by pneumonia with hypoxemia. Hospitalized patients and particularly those admitted to intensive care unit (ICU) may encounter a cascade of coagulopathies, which may lead to macrovessel thrombotic events such as pulmonary embolism (PE), deep vein thrombosis (DVT), or arterial thromboembolism (ATE). These events can result in serious life-threatening diseases including cerebrovascular stroke and myocardial infarction. Despite all available information about the incidence, prevention, and treatment of venous thromboembolism (VTE) among hospitalized patients, few data are available on the incidence of both symptomatic and subclinical VTE after discharge. Therefore, there is no precise suggestion or guideline for prophylaxis against VTE in post-discharge period, and some controversies exist over the current guidelines. In the present study, we aimed to review and summarize available literature upon incidence, prevention, diagnosis, and therapeutic approaches for VTE in COVID-19 patients. Also, the pathogenic mechanisms of VTE in infected individuals with COVID-19 were discussed.
Keywords: COVID-19; D-dimer; coagulopathy; deep vein thrombosis; venous thromboembolism.
. 2023 Jan-Dec;29:10760296221148477.
doi: 10.1177/10760296221148477.
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis
Forough Mehrabi[SUP] 1 [/SUP], Melina Farshbafnadi[SUP] 2 [/SUP], Nima Rezaei[SUP] 3 [/SUP]
Affiliations
- PMID: 36596272
- DOI: 10.1177/10760296221148477
Abstract
Coronavirus disease 2019 (COVID-19) affects the respiratory system of patients and is characterized by pneumonia with hypoxemia. Hospitalized patients and particularly those admitted to intensive care unit (ICU) may encounter a cascade of coagulopathies, which may lead to macrovessel thrombotic events such as pulmonary embolism (PE), deep vein thrombosis (DVT), or arterial thromboembolism (ATE). These events can result in serious life-threatening diseases including cerebrovascular stroke and myocardial infarction. Despite all available information about the incidence, prevention, and treatment of venous thromboembolism (VTE) among hospitalized patients, few data are available on the incidence of both symptomatic and subclinical VTE after discharge. Therefore, there is no precise suggestion or guideline for prophylaxis against VTE in post-discharge period, and some controversies exist over the current guidelines. In the present study, we aimed to review and summarize available literature upon incidence, prevention, diagnosis, and therapeutic approaches for VTE in COVID-19 patients. Also, the pathogenic mechanisms of VTE in infected individuals with COVID-19 were discussed.
Keywords: COVID-19; D-dimer; coagulopathy; deep vein thrombosis; venous thromboembolism.